Detect and monitor brain diseases through typing cadence

How do we perform our magic?

Simple: Measure typing inconsistency

Detect and monitor neurological diseases and psychiatric disorders through typing cadence.

NeuraMetrix Typing Cadence (TC) is a patented digital biomarker (US Patents 10,694,947 and 10,694,987) measuring typing inconsistency.

Why do we do what we do?

Measurement is a huge barrier to better care for brain diseases and psychiatric disorders.

Or as Dr. Adam Gazzaley puts it

Imprecise, inaccessible, and outdated assessments of cognition dominate the mental health world - Dr. Adam Gazzaley, UCSF

We want to enable dramatically better care for Neurological and Psychiatry patients through a much more precise and accurate measure of brain health over time.​​​

From the experts


We have been looking for this for 30 years

- Dr. Robert W. Mahley, MD, PhD – Gladstone Institutes

We train our Huntington’s patients intensively. I am amazed that the effects are so clearly shown in the inconsistency scores.

- Dr. Christina Lang, MD – Universität Ulm, Germany

This will revolutionize how we treat these poor patients

- CTO of major hospital system in Scandinavia

NeuraMetrix technology has potential to provide first-in-class early detection of affective disorders potentially fast-tracking diagnosis and reducing burden of illness

- Dr. Martin Schalling, MD, Professor of Medical Genetics Karolinska Institutet,  Chair Swedish Mental Health Fund

Some of our Partners

Sign up for our newsletter

Get the latest news from and about NeuraMetrix